Issue 14

Significant Growth Predicted for CDMO Market

Why not sign up for our future email newsletters? Sign up here.

Included in this issue:

LEAD STORY

Global CMO & CDMO Market Predicted to Reach $40 Billion by 2033

A recently published report from Future Market Insights highlights significant potential for global CMO/CDMO market growth; with projections suggesting a significant increase in value from $22.5 bn in 2023 to $39.4 bn by 2033. 

Read more here.

FEATURED STORIES

Samsung Biologics Secures $1.06 Billion Manufacturing Deal with US Pharma

Read more here.

Lonza Group Welcomes New CEO 

Read more here.

CordenPharma to Invest €900 Million to Meet GLP-1 Drug Demand

Read more here.

Aptamer Group and AstraZeneca Announce siRNA Delivery Collaboration

Read more here.

Lotte Biologics to Invest $3 Billion in Songdo Biomanufacturing Expansion

Read more here.

MedPharm and Tergus Pharma Merge to Form Topical & Transepithelial CDMO

Read more here.

Novartis Announces Closure of its San Diego Research Facility

Read more here.

Thermo Fisher to Acquire Swedish Proteomics Firm

Read more here.

Roche Earns CE Mark for AI-Enabled Medical Device

Read more here.

Eurofins CDMO Alphora Expands API Capacity with New Facility

Read more here.